4//SEC Filing
Lee Sung 4
Accession 0001628280-24-013555
CIK 0001706431other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 12:18 PM ET
Size
4.8 KB
Accession
0001628280-24-013555
Insider Transaction Report
Form 4
Lee Sung
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-03-27$9.89/sh−6,008$59,404→ 100,492 total
Footnotes (1)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001793200
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 12:18 PM ET
- Size
- 4.8 KB